Grand River Aseptic Manufacturing, Inc. (GRAM) has successfully completed its fourth FDA inspection at its contract parenteral manufacturing facility in Grand Rapids, MI.   The seven-day inspection included a general GMP and a Pre-Approval Inspection, which found GRAM to be in compliance with Current Good Manufacturing Practices. GRAM also passed the Pre-Approval Inspection, with no Form 483 observations issued.    Tom Ross, president and chief executive officer at GRAM said, “GRAM team memb...